Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Human Cytomegalovirus Seropositivity Linked to Less Bone Erosion in RA Patients

Publish date:: January 28, 2020

Key clinical point: Rheumatoid arthritis (RA) patients with positive human cytomegalovirus (HCMV) status showed less bone erosion, compared with patients with negative HCMV status.

Major finding: At a 1-year follow-up, bone erosion was significantly lower in RA patients with positive HCMV, compared with those who tested negative for HCMV (16.1% vs. 25.2%).

Study details: The data come from a review of 273 HCMV seropositive and 214 HCMV seronegative RA patients.

Disclosures: The study was supported by Institutional grants from the French National Institute of Health and Medical Research (INSERM). The researchers had no financial conflicts to disclose.

Citation:

Rauwel B et al. Arthritis Res Ther. 2020 Jan 20. doi: 10.1186/s13075-020-2098-1.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Rheumatoid Arthritis

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Tocilizumab, methotrexate combo equals tocilizumab alone for preventing progression,

Biomarker-based prognostic score identifies cardiovascular risk in RA,

Early life exposure to famine raises risk of RA in adulthood,